Prognosis Study Guide

📖 Core Concepts Prognosis – a medical prediction of a disease’s future course (duration, functional level, pattern). Complete prognosis – must state duration, functional outcome, and course pattern (e.g., steady decline, intermittent crises). Population‑based prognosis – statistical estimate for a group (e.g., “45 % of severe septic‑shock patients die within 28 days”). Individual prognosis – tailors the population estimate by adding patient‑specific factors (physical, mental, treatment, comorbidities). Prognostic scoring systems – structured tools that combine multiple variables to predict outcomes for a specific disease. Progression‑Free Survival (PFS) – time during/after treatment when the disease does not get worse. Survival Rate – % of patients alive after a defined interval from diagnosis. Survival Time – absolute length of life remaining from a reference point (usually diagnosis). --- 📌 Must Remember A complete prognosis always includes duration, functional level, course pattern. Population estimates are highly accurate for large groups but may mislead for a single patient. Numerical scores (e.g., APACHE II) outperform physician intuition in ICU mortality prediction. Hy’s Law → predicts severe drug‑induced liver injury. Exercise stress test post‑MI → predicts future cardiac events. Manchester score → small‑cell lung cancer; International Prognostic Index → non‑Hodgkin lymphoma; both are disease‑specific survival predictors. --- 🔄 Key Processes Generate a Prognosis Identify the disease’s typical natural history. Gather patient‑specific modifiers (physical health, mental state, current treatments, comorbidities). Choose an appropriate prognostic scoring system if available. Combine population data with individual modifiers → produce duration, functional level, and pattern statements. Apply a Scoring System (e.g., APACHE II) Collect acute physiology variables (temperature, MAP, heart rate, labs, etc.). Add chronic health points (e.g., severe organ dysfunction). Sum to obtain a total score. Convert the total score to a predicted mortality percentage using the published table. --- 🔍 Key Comparisons Individual prognosis vs. Population prognosis Individual: Adjusts for personal health, mental status, treatment plan. Population: Purely statistical, no patient‑level adjustments. Numerical scoring systems vs. Physician intuition Scoring systems: Objective, reproducible, higher accuracy in ICU mortality. Intuition: Subjective, prone to bias, less reliable for complex cases. Progression‑Free Survival vs. Survival Time PFS: Focuses on disease stability, regardless of death. Survival Time: Measures total life length from a start point. --- ⚠️ Common Misunderstandings “Population prognosis = patient’s fate.” Reality: It gives a baseline; individual modifiers can shift the outcome substantially. “A high score always means death soon.” Reality: Scores predict probability, not certainty; clinical context matters. “Progression‑Free Survival equals overall survival.” Reality: PFS stops counting once disease progresses, even if the patient lives much longer. --- 🧠 Mental Models / Intuition “Layered forecast” – Think of prognosis as a base layer (population data) plus adjustment layers (patient factors). Each layer tweaks the prediction up or down. “Score as a thermometer” – Higher numeric scores = hotter (higher risk). Use the thermometer to quickly gauge severity before diving into detailed numbers. --- 🚩 Exceptions & Edge Cases Rare diseases – May lack robust population data; rely more heavily on expert opinion and case series. Rapidly changing therapies – New treatments can invalidate older survival rates; always check the most recent literature. Patients with multiple comorbidities – Scores that omit key comorbidities may under‑estimate risk; consider supplemental clinical judgment. --- 📍 When to Use Which Use disease‑specific scores (Manchester, IPI) when the cancer type matches the tool. Use APACHE II for critically ill ICU patients where 7‑day mortality is the question. Use Hy’s Law only for suspected drug‑induced liver injury; not for other organ toxicities. Use exercise stress test as a cardiac prognostic tool only after myocardial infarction, not for unrelated chest pain. When individual factors dominate (e.g., young patient with severe disease but excellent functional reserve), prioritize personalized adjustment over raw population percentages. --- 👀 Patterns to Recognize “Score + 10% = mortality jump” – In many ICU scores, each 5‑point increase often adds 10 % absolute mortality risk. “Sudden crisis pattern” – When the outline mentions “intermittent crisis” or “sudden unpredictable crisis,” think of diseases with acute exacerbations (e.g., COPD flare, sickle‑cell crisis). “Survival metric cue” – If a question gives a time frame (e.g., 5‑year), it’s asking for survival rate; if it asks for “time until progression,” it’s PFS. --- 🗂️ Exam Traps Distractor: “The Manchester score predicts overall survival for all lung cancers.” Why wrong: It is specific to small‑cell lung cancer, not all lung cancers. Distractor: “APACHE II predicts death within 30 days for any hospitalized patient.” Why wrong: It is validated mainly for critically ill ICU patients and focuses on short‑term (≈7‑day) mortality. Distractor: “A 45 % 28‑day mortality in severe septic shock means every individual will die in 28 days.” Why wrong: That figure is a population estimate; individual outcomes vary with comorbidities and interventions. Distractor: “Progression‑Free Survival includes death from any cause.” Why wrong: PFS ends at disease progression or death; the metric is usually reported censoring deaths unrelated to progression. ---